Health Scores Near 01260, South Lee, Massachusetts
You may also like
The Provider Score for the Prostate Cancer Score in 01260, South Lee, Massachusetts is 99 when comparing 34,000 ZIP Codes in the United States.
An estimate of 100.00 percent of the residents in 01260 has some form of health insurance. 6.95 percent of the residents have some type of public health insurance like Medicare, Medicaid, Veterans Affairs (VA), or TRICARE. About 100.00 percent of the residents have private health insurance, either through their employer or direct purchase. Military veterans should know that percent of the residents in the ZIP Code of 01260 have VA health insurance. Also, percent of the residents receive TRICARE.
For the 165 residents under the age of 18, there is an estimate of 0 pediatricians in a 20-mile radius of 01260. An estimate of 0 geriatricians or physicians who focus on the elderly who can serve the 23 residents over the age of 65 years.
In a 20-mile radius, there are 219 health care providers accessible to residents in 01260, South Lee, Massachusetts.
Health Scores in 01260, South Lee, Massachusetts
| Prostate Cancer Score | 97 |
|---|---|
| People Score | 87 |
| Provider Score | 99 |
| Hospital Score | 55 |
| Travel Score | 50 |
| 01260 | South Lee | Massachusetts | |
|---|---|---|---|
| Providers per 10,000 residents | 0.00 | 0.00 | 0.00 |
| Pediatricians per 10,000 residents under 18 | 0.00 | 0.00 | 0.00 |
| Geriatricians per 10,000 residents over 65 | 0.00 | 0.00 | 0.00 |
The analysis focuses on prostate cancer care within the ZIP code 01260 and the broader primary care landscape of South Lee, aiming to provide a comprehensive "Prostate Cancer Score" assessment. This score will consider various factors, including physician-to-patient ratios, the presence of standout practices, the adoption of telemedicine, and the availability of mental health resources, all crucial elements in a patient's journey through diagnosis and treatment.
The initial assessment begins with the physician-to-patient ratio. A higher ratio, indicating more physicians per capita, generally suggests better access to care. However, simply counting doctors is insufficient. The analysis must also consider the specialties of these physicians. Are there sufficient urologists, oncologists, and radiation oncologists within a reasonable distance? This is particularly critical for prostate cancer, which often requires a multidisciplinary approach. Furthermore, the analysis will investigate the age and experience of the physicians, as these factors can influence the quality of care.
Standout practices are another key component of the score. These are medical facilities or individual physicians recognized for excellence in prostate cancer care. This recognition might come from patient reviews, peer recognition, or accreditations from reputable organizations. The analysis will examine the practices' use of advanced diagnostic tools, such as MRI and genomic testing, which can aid in early detection and personalized treatment planning. The availability of advanced treatment options, including minimally invasive surgery, radiation therapy, and targeted therapies, will also be a significant factor.
Telemedicine adoption is increasingly important, especially in rural areas. Telemedicine can improve access to care by reducing the need for travel, particularly for follow-up appointments and consultations. The analysis will assess the extent to which physicians in the area offer telemedicine services, the types of services offered (e.g., virtual consultations, remote monitoring), and the ease with which patients can access these services. The availability of telehealth can be a significant factor in patient convenience and adherence to treatment plans.
Mental health resources are often overlooked but are crucial for patients facing a prostate cancer diagnosis. The emotional toll of diagnosis, treatment, and potential side effects can be significant. The analysis will investigate the availability of mental health services, such as therapists and support groups, specifically for prostate cancer patients. The integration of mental health services within the medical practices, such as on-site counseling or referrals to specialists, will be a positive indicator.
The "Prostate Cancer Score" will be a composite measure, weighting each factor based on its perceived importance. The physician-to-patient ratio, access to specialists, and the presence of standout practices will likely carry significant weight. Telemedicine adoption and mental health resources will also be considered, although perhaps with slightly less weight. The score will be presented on a scale, allowing for easy comparison of different providers and practices.
In South Lee, the primary care landscape plays a crucial role in prostate cancer care. Primary care physicians are often the first point of contact for patients experiencing symptoms. Their awareness of prostate cancer screening guidelines and their ability to make timely referrals to specialists are essential. The analysis will assess the availability of primary care physicians in South Lee, the average wait times for appointments, and the ease with which patients can access these services.
The analysis will also consider the geographic distribution of healthcare resources. Are there significant disparities in access to care within the area? Are patients in more remote locations at a disadvantage? The analysis will use geographic information systems (GIS) to map the locations of physicians, hospitals, and other healthcare facilities, providing a visual representation of access to care.
The overall goal of this analysis is to provide a clear and concise assessment of the quality of prostate cancer care in the specified geographic areas. The "Prostate Cancer Score" will be a valuable tool for patients, allowing them to make informed decisions about their healthcare. It will also be useful for healthcare providers, highlighting areas where improvements can be made.
The final "Prostate Cancer Score" will reflect the overall quality of care available in the region. This includes not only the availability of specialists and advanced treatment options but also the accessibility of care, the integration of mental health services, and the adoption of telemedicine. The score will provide a comprehensive overview, allowing patients to navigate the healthcare system with greater confidence.
This analysis is designed to empower patients and healthcare providers. By providing a clear and objective assessment of the prostate cancer care landscape, it can help patients make informed decisions about their health and encourage healthcare providers to strive for excellence. The "Prostate Cancer Score" is a dynamic measure, reflecting the ever-changing healthcare landscape.
The analysis will also consider the cost of care. The affordability of healthcare is a major concern for many patients. The analysis will investigate the average cost of prostate cancer screenings, diagnostic tests, and treatments in the area. It will also consider the availability of financial assistance programs for patients who are unable to afford care.
The analysis will conclude with a summary of the findings, highlighting the strengths and weaknesses of the prostate cancer care landscape in the specified geographic areas. It will also provide recommendations for improvement, based on the analysis. These recommendations might include suggestions for increasing the physician-to-patient ratio, improving access to telemedicine services, or expanding the availability of mental health resources.
To gain a deeper understanding of the geographic distribution of healthcare resources, and to visualize the data presented in this analysis, we encourage you to explore CartoChrome maps. Their interactive mapping tools can provide a visual representation of the data, offering insights into access to care and potential disparities. Visit their website today to explore how CartoChrome can help you visualize and understand the healthcare landscape.
Reviews
No reviews yet.
You may also like
